3. Significant Strategic Drug Development Collaborations - Related Parties |
6 Months Ended |
|---|---|
Jun. 30, 2016 | |
| Significant Strategic Drug Development Collaborations - Related Parties | |
| Significant Strategic Drug Development Collaborations - Related Parties |
The Company has entered into various research, development, license and supply agreements with Shire plc (Shire), formerly Baxalta Incorporated (a spinoff of the biopharmaceuticals business from Baxter Healthcare SA and Baxter Healthcare Corporation), SynBio LLC (SynBio), Serum Institute of India (Serum) and Pharmsynthez. The Company and its collaborative partners continue to engage in research and development activities with no resultant commercial products through June 30, 2016. No amounts were recognized as revenue related to these agreements during the six months ended June, 2016 or 2015. |